StockWatch
·

PHARMAIDS PHARMACEUTICALS LTD. Q4 FY25 Results

PHARMAIDQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue4.771.3%
Total Income4.842.6%
Expenditure10.3018.2%
PBT-5.4034.6%
Net Profit-4.8059.3%
OPM-80.71%
NPM-99.20%35.28pp
EPS1.11301.8%
View full financials

Informational and educational content only. Not investment advice.